MEDIGEN GROUP
MediGen Group LLC is a venture capital firm specializing in investments in seed,start-up, and early stage companies. The firm seeks to invest in life science companies. The firm prefers to take a seat on the board of its portfolio company. MediGen Group LLC was founded in 2001 and is based in Houston, Texas.
MEDIGEN GROUP
Founded:
2001-01-01
Status:
Active
Similar Organizations
Almond Tree Capital Fund
Almond Tree Capital LLC is a venture capital firm specializing in investments in startups and health technology.
Annapolis Capital
Annapolis Capital Limited is a venture capital firm specializing in investments in startups, early stage companies,
SproutBox
SproutBox LLC is a venture capital firm specializing in investments in startup and early stage companies.
Current Employees Featured
More informations about "MediGen Group"
Corporate Structure | 基亞生物科技股份有限公 …
37 rows · Management and Maintenance of GTP Lab.See details»
基亞生物科技股份有限公司／Medigen Biotech Corp. | Innovations …
Organization and Operation of Internal Audit; Corporate Governance Status; Corporate Regulations; Corporate Social Responsibility Status. Management; Careers; Subsidiaries. …See details»
MediGen Group - Crunchbase Investor Profile & Investments
MediGen Group LLC is a venture capital firm specializing in investments in seed,start-up, and early stage companies. The firm seeks to invest in life science companies. The firm prefers to …See details»
Our Vision | 基亞生物科技股份有限公司／Medigen Biotech Corp.
Medigen aims to become one of the leading biotech companies in Asia and then a multinational biomedical group through expansion into new businesses and merger and acquisition. Based …See details»
Medigen Vaccine Biologics Corporation - Wikipedia
The Medigen Vaccine Biologics Corporation (MVC; traditional Chinese: 高端疫苗生物製劑; simplified Chinese: 高端疫苗生物制剂; pinyin: Gāoduān Yìmiáo Shēngwù Zhìjì) is a pharmaceutical company headquartered in Neihu, Taipei, Taiwan. See details»
Medigen Company Profile 2024: Valuation, Funding
Developer of infectious diseases vaccines designed to fight against virus cells.See details»
Medigen - Crunchbase Company Profile & Funding
Medigen is a vaccine company that develops vaccines against infectious diseases and chronic diseases. View contacts for Medigen to access new leads and connect with decision-makers.See details»
Medigen Biotechnology - Crunchbase Company Profile & Funding
Medigen Biotechnology focuses on the development of new products in the two major areas of “hepatopathy” and “cancer” in Asia. View contacts for Medigen Biotechnology to access new …See details»
Home - Medigen
Medigen, Inc. is a biomedical company developing safe and effective vaccines against emerging diseases. Our goal is to protect human life with life-long immunity. Focus on vaccine safety …See details»
Why Taiwan approved its own vaccine before phase III trials
Sep 3, 2021 · Medigen. Medigen’s candidate is a two dose vaccine that Taiwan’s FDA approved for people aged 20 and older. The government has ordered five million doses, which the …See details»
Medigen shares COVID vaccine tech with WHO in world-first deal
Aug 30, 2023 · Medigen’s vaccine unit was among three licensors to share tech via the WHO’s COVID-19 Technology Access Pool (C-TAP) in new deals, alongside research institutes in …See details»
MVC COVID-19 vaccine - Wikipedia
On 26 October 2021, the World Health Organization (WHO) selected Medigen vaccine as one of its Solidarity Trial Vaccines. The trial is designed to rapidly evaluate the efficacy and safety of …See details»
MediGen Group - Contacts, Employees, Board Members
MediGen Group LLC is a venture capital firm specializing in investments in seed,start-up, and early stage companies.See details»
Medigen BioMedical Group Introduction
Organization and Operation of Internal Audit; Corporate Governance Status; Corporate Regulations; Corporate Social Responsibility Status. Management; Careers; Subsidiaries. …See details»
Medigen License to C-TAP - World Health Organization (WHO)
The Medicines Patent Pool signed a worldwide license with Medigen Vaccine Biologics Corp. (“Medigen”) for a COVID-19 vaccine based on the COVID-19 spike protein sequence that …See details»
English | Languages | 基亞生物科技股份有限公司／Medigen …
Feb 11, 2020 · Medigen and NKure in collaboration to develop Medigen’s natural killer cell therapy (Magicell®-NK) in India.See details»
Solidarity Trial Vaccines - World Health Organization (WHO)
These are a spike adjuvanted vaccine developed by Medigen, and a DNA vaccine encoding the spike protein developed by Inovio.See details»
Safety and immunogenicity of a Recombinant Stabilized Prefusion …
We conducted a first-in-human, phase 1, dose-escalation study done to assess the safety, and immunogenicity of three dose levels of MVCCOV1901 administered to healthy adults as two …See details»
Vaccine | 基亞生物科技股份有限公司／Medigen Biotech Corp.
With modern cell-cultivation platform and extensive international partnerships, MVC develops novel cell-based vaccines and affordable biosimilars to prevent regional infectious disease in …See details»
WHO statement on Solidarity Trial Vaccines - World Health …
Oct 26, 2021 · Following the recommendation of the working group, 2 candidate vaccines are now included in the Solidarity Trial Vaccines. These are a protein subunit vaccine from Medigen, …See details»